易善复在原发性肝癌患者TACE治疗中的护肝作用  

作　　者：王友春[1] 马建党[2] 范银忠[1] 

机构地区：[1]河南省洛阳市中心医院消化内科,471009 [2]河南省洛阳市中心医院检验科,471009

出　　处：《中国实用医药》2013年第3期34-35,共2页China Practical Medicine

摘　　要：目的观察易善复治疗原发性肝癌患者行肝动脉化疗栓塞(transcatheter arterial chemoem-bolization TACE)后发生肝损伤的疗效。方法 56例原发性肝癌患者随机分为两组,每组各28例,均给予TACE治疗,治疗组在应用还原型谷胱甘肽保肝基础上加用易善复静点930 mg/d,观察术后3 d、术后7 d肝功能指标的变化。结果两组转氨酶、胆红素在TACE治疗后均明显升高(P<0.01),经易善复治疗后,治疗组各指标均较对照组明显好转(P<0.01)结论易善复治疗原发性肝癌患者TACE后肝损伤效果良好,能改善患者的预后。Objective To observe the Essentiale treatment of primary liver cancer in patients with hepatic arterial chemoembolization transcatheter arterial chemoembolization TACE） of liver injury after treatment.Methods 56 patients with primary liver cancer were randomly divided into two groups of 28 patients were treated with TACE treatment,the treatment group in the application of liver glutathione based on the use Essentiale infusion 930 mg/d,observed after 3 days,7 days after the changes in liver function.Results There were transaminases,bilirubin were significantly increased after TACE treatment（P 0.01）,by Essentiale treatment,the treatment group than in the control group significantly improved index（P 0.01） Conclusion Essentiale treatment of primary liver cancer after TACE in patients with liver injury to good effect,can improve the prognosis of patients.

关 键 词：易善复 原发性肝癌 经导管动脉化疗栓塞 肝损伤 预后 

分 类 号：R735.7[医药卫生—肿瘤]